Saba Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Saba Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,073,662	Closed	-$11.2M	–	773
2023 Q1	$11.2M	Hold	1,073,662	–	–	0.21%	154
2022 Q4	$11M	Hold	1,073,662	–	–	0.15%	235
2022 Q3	$10.8M	Hold	1,073,662	–	–	0.12%	310
2022 Q2	$10.7M	Buy	1,073,662 +500,000	+87%	+$4.99M	0.12%	294
2022 Q1	$5.72M	Buy	573,662 +40,739	+8%	+$404K	0.08%	404
2021 Q4	$5.33M	Buy	+532,923	New	+$5.28M	0.08%	355

Saba Capital Management's LVAC Position: Q2 2023 in Review

Saba Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 1,073,662 shares — an estimated $11.2M sold.

Saba Capital Management first reported a position in LVAC in Q4 2021 and held it in 6 quarters. The position peaked at $11.2M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Saba Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Saba Capital Management sold 1,073,662 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $11.2M.
Saba Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Saba Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $11.2M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Saba Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.